Both etanercept and adalimumab improve health related quality of life in adult patients with rheumatoid arthritis and juvenile idiopathic arthritis

被引:0
|
作者
Laas, Karin [1 ]
Puolakka, Kari [2 ]
Kautiainen, Hannu [3 ]
Leirisalo-Repo, Marjatta [1 ]
机构
[1] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland
[2] Lappeenranta Cent Hosp, Lappeenranta, Finland
[3] Rheumatism Fdn Hosp, Heinola, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:45 / 45
页数:1
相关论文
共 50 条
  • [1] Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis
    Marzan, Katherine Anne B.
    Reiff, Andreas Otto
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (05) : 549 - 558
  • [2] Adalimumab improves health-related quality of life in rheumatoid arthritis patients
    Strand, V
    Weisman, MH
    Nichol, MB
    Knight, TK
    Chang, K
    Chartash, EK
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 356 - 356
  • [3] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    María M. Katsicas
    Ricardo A. G. Russo
    Clinical Rheumatology, 2009, 28 : 985 - 988
  • [4] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and infliximab
    Katsicas, M. M.
    Russo, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 551 - 552
  • [5] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [6] Methotrexate (MTX) and etanercept (ETN) improve the health-related quality of life (HRQOL) of children with juvenile idiopathic arthritis (JIA).
    Gutiérrez-Suárez, R
    Céspedes, A
    Ravelli, A
    Murray, K
    Gerloni, V
    Wulffraat, N
    Oliveira, S
    Walsh, J
    Calvo, I
    Alpigiani, MG
    Lahdenne, P
    Machado, C
    Cortis, E
    Lepore, L
    Hall, A
    Martín, A
    Burgos-Vargas, R
    Ruperto, N
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 426 - 426
  • [7] Health-related Quality of Life Outcomes of Adalimumab for Patients With Rheumatoid Arthritis in Korea
    Lee, Myeung-su
    Lee, Chang Hoon
    Lee, Hye Soon
    Sung, Yoon-Kyoung
    Choi, Jung Ran
    Park, Kyungsu
    Lim, Mi-Kyoung
    Choi, Byoong Yong
    Kim, Hyoun-Ah
    Choi, Seung Won
    Lee, Yusun
    Yoo, Wan-Hee
    JOURNAL OF RHEUMATIC DISEASES, 2021, 28 (02): : 68 - 75
  • [8] Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practice
    Laas, K.
    Peltomaa, R.
    Puolakka, K.
    Kautiainen, H.
    Leirisalo-Repo, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 315 - 320
  • [9] Quality-of-life measurements in juvenile rheumatoid arthritis patients treated with etanercept
    Robinson, RF
    Nahata, MC
    Hayes, JR
    Rennebohm, R
    Higgins, G
    CLINICAL DRUG INVESTIGATION, 2003, 23 (08) : 511 - 518
  • [10] EARLY IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE DURING TREATMENT WITH ETANERCEPT AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ROUTINE PRACTICE
    Laas, K.
    Peltomaa, R.
    Puolakka, K.
    Kautiainen, H.
    Leirisalo-Repo, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) : 407 - 408